Lidothol Gel
Product Images NDC 76420-253

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lidothol (NDC 76420-253). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Lidotholinsertp1 (Lidothol Gel Package Insert Page 1)

Lidotholinsertp1 (Lidothol Gel Package Insert Page 1)
Lidothol Gel is a prescription topical gel consisting of Lidocaine 4.5% and Menthol 5%, indicated for the relief of pain associated with arthritis, backache, cramps, discomfort, neckache, soreness, sprains, and strains. The general precautions must be followed to avoid adverse reactions. The patient with severe hepatic disorders must be cautious while using the product due to their inability to metabolize the content normally. It is not recommended for patients with drug sensitivities. The medicine should not be swallowed, heated, or exposed to an open flame. Some patients are at a higher risk of developing methemoglobinemia. The dosage must not exceed the limit to avoid saturation of lidocaine blood concentration. Lidocaine and its metabolites are primarily excreted from the body through the kidneys. The makeup of the product allows a partial analgesic effect without the administration of complete sensory block.*
FDA Label Image

Lidotholinsertp2 (Lidothol Gel Package Insert Page 2)

Lidotholinsertp2 (Lidothol Gel Package Insert Page 2)
The text provides information on the dosage and administration of Lidothol Gel for the treatment of pain. It advises the user to apply the product directly to the skin and not to reapply it if there is any irritation or burning sensation. The handling and disposal of the product must be done with care. The text also discusses possible adverse side effects, systemic reactions to the medication, overdosage, and information for pregnant or breastfeeding women. It says that use of local anesthetics may cause methemoglobinemia, a serious condition that must be treated promptly. Overall, it offers guidance on the proper use of Lidothol Gel, including its potential risks and side effects.*
FDA Label Image

Lidotholbox (Lidothol Gel Label)

Lidotholbox (Lidothol Gel Label)
This is a description of a medicated gel called "Lidothol Gel" containing Lidocaine 4.5% and Menthol 5% in a tube size of 3.5 oz. The product is for prescription use only and must not be dispensed without a doctor's prescription. The drug comes with a caution note to keep it out of the reach of children and store it in a controlled room temperature according to USP guidelines. The NDC number is 76420-253-04, and it was manufactured for Terrain Pharmaceuticals. There are also lot and batch numbers available for the formulation. There are three repetitions of the product's name and NDC with a reference ID of "SN" and "ay 35" in the text, which could be typos.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.